Table B1.

P-values of mentioned interaction effects in the re-analysis of Arns et al. (2016) with data only of MDD patients who had measurements after 8 weeks (thus excluding FAA baseline measurements of patients who did not return for follow-up).

	Original analysis	Original analysis without patients with no follow-up	Re-analysis with week-8 FAA*
Females SSRI: Response	P = .001	P = .001	P = .028
Females venlafaxine: Response	P = .070	P = .011	P = .821